Tibet Cheezheng Tibetan Medicine Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kailie Liu

Algemeen directeur

CN¥2.9m

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	14.1yrs
Eigendom CEO	0.08%
Management gemiddelde ambtstermijn	10.6yrs
Gemiddelde ambtstermijn bestuur	6.5yrs

Recente managementupdates

Recent updates

CEO

Kailie Liu (60 yo)

14.1yrs

Tenure

CN¥2,866,800

Compensatie

Mr. Kailie Liu serves as the President at Tibet Cheezheng Tibetan Medicine Co.,Ltd. Mr. Liu serves as General Manager of Tibet Yutuo Tibetan Medicine Group Co., Ltd., General Manager of Beijing Qizheng Tia...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kailie Liu	President & Non-Independent Director	no data	CN¥2.87m	0.084% CN¥ 10.1m
Xiaomei Yao	Financial Director	6.3yrs	CN¥755.30k	0.014% CN¥ 1.7m
Jianqin Xiao	Vice President of Operations	10.8yrs	CN¥1.22m	0.050% CN¥ 6.1m
Weiwu Chen	Chief Scientific Officer	no data	CN¥954.40k	0.025% CN¥ 3.0m
Zhiqiang Wang	VP & Director of Administration Department	10.8yrs	CN¥1.04m	0.034% CN¥ 4.0m
Ping Feng	VP & Secretary of the Board of Directors	10.5yrs	CN¥994.40k	0.034% CN¥ 4.0m
Jun Li	Vice President	no data	CN¥1.47m	0.036% CN¥ 4.4m
Min Zhao	Vice President	no data	CN¥1.06m	0.0051% CN¥ 618.2k
Haijian Xia	Vice President	no data	CN¥1.50m	0.015% CN¥ 1.8m

10.6yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 002287 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 10.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kailie Liu	President & Non-Independent Director	14.1yrs	CN¥2.87m	0.084% CN¥ 10.1m
Jufang Lei	Chairman	17.1yrs	CN¥735.60k	geen gegevens
Yu Jia	Chairman of the Supervisory Board	6.5yrs	geen gegevens	geen gegevens
Chunyu Li	Independent Director	3.5yrs	CN¥100.00k	geen gegevens
Zhijian He	Non-Employee Supervisor	10.8yrs	geen gegevens	geen gegevens
Xielong Luo	Non-Independent Director	6.5yrs	CN¥100.00k	geen gegevens
Ouzhu Suolang	Non-Independent Director	10.8yrs	CN¥100.00k	geen gegevens
Yurong Wang	Independent Director	3.9yrs	CN¥100.00k	geen gegevens
Tenzin Wanma	Supervisor	6.5yrs	geen gegevens	geen gegevens
Yirui Wang	Supervisor	5.2yrs	geen gegevens	geen gegevens

6.5yrs

Gemiddelde duur

55.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 002287 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).

Tibet Cheezheng Tibetan Medicine Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Insufficient new directors

Tibet Cheezheng Tibetan Medicine Co., Ltd., Annual General Meeting, May 10, 2024

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.13 in 3Q 2023)

Investor sentiment improves as stock rises 24%

Tibet Cheezheng Tibetan Medicine Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Insufficient new directors

Second quarter 2024 earnings released: EPS: CN¥0.43 (vs CN¥0.41 in 2Q 2023)

Tibet Cheezheng Tibetan Medicine Co., Ltd. to Report First Half, 2024 Results on Aug 24, 2024

First quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.17 in 1Q 2023)

New minor risk - Earnings quality

Tibet Cheezheng Tibetan Medicine Co., Ltd., Annual General Meeting, May 10, 2024

Full year 2023 earnings released: EPS: CN¥1.10 (vs CN¥0.89 in FY 2022)

Tibet Cheezheng Tibetan Medicine Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment deteriorates as stock falls 16%

Tibet Cheezheng Tibetan Medicine Co., Ltd. to Report Fiscal Year 2023 Results on Apr 19, 2024

Third quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.23 in 3Q 2022)

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.48 (vs CN¥0.27 in 2Q 2022)

Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on July 20, 2023

Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Year 2022

First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.17 in 1Q 2022)

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.65 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.27 (vs CN¥1.69 in 2Q 2021)

Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 19 July 2022

Tibet Cheezheng Tibetan Medicine Co., Ltd. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.19 in 1Q 2021)

Now 20% undervalued after recent price drop

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Third quarter 2021 earnings released: CN¥0.65 loss per share (vs CN¥0.20 profit in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥1.69 (vs CN¥0.33 in 2Q 2020)

Second quarter 2021 earnings released: EPS CN¥1.69 (vs CN¥0.33 in 2Q 2020)

Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥0.77 (vs CN¥0.69 in FY 2019)

New 90-day low: CN¥23.03

Tibet Cheezheng Tibetan Medicine Co., Ltd. to Report Fiscal Year 2020 Results on Apr 16, 2021

Full year 2020 earnings released: EPS CN¥0.77 (vs CN¥0.69 in FY 2019)

New 90-day low: CN¥23.08

New 90-day high: CN¥30.48

New 90-day high: CN¥29.60

Market bids up stock over the past week

New 90-day low: CN¥24.90

Third quarter earnings released

Tibet Cheezheng Tibetan Medicine Co., Ltd. to Report Q3, 2020 Results on Oct 23, 2020

First half earnings released

Tibet Cheezheng Tibetan Medicine Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd